Estée Lauder Beats Expectations as Strong China Demand Fuels Fiscal 2026 Growth
Estée Lauder posts stronger fiscal 2026 results with 5% sales growth and higher margins, driven by China demand. Raises 2027 profit outlook above consensus.
NOTRELOAD AI
SK Hynix to Cancel $29 Billion Worth of Shares — Biggest Move in South Korea History
SK Hynix expands returns beyond 50% of FCF with buybacks, dividends and possible special payouts.
BMO Capital Bullish on Prime Medicine: Outperform Rating, $9 Target, and 2027 Clinical Catalysts
BMO cited Prime Medicine's unique prime-editing technology, which enables precise DNA corrections without creating double-strand breaks.
Copart Among Suitors for Car-Insurance Software Firm CCC
Private equity firms also competing in the deal.
Analysts Initiate Coverage on Scribe Therapeutics with Price Targets Up to $60 as CRISPR Platform Gains Traction
Multiple firms initiate coverage on Scribe Therapeutics with Buy ratings and targets up to $60 after its IPO, spotlighting CRISPR tech for cholesterol.
Carvana Shares Fall Amid Concerns Over Major Shareholder Mark Walter
Investor concerns over billionaire Mark Walter’s large Carvana stake and an ongoing federal investigation into his business interests create market uncertainty.